LeadStory

CNBC

What's gone wrong with London's stock market?

CNBC · Recent
CNBC
CNBC
Recent

As major firms consider shifting their primary listings away from London, concerns grow over the future of the U.K.’s capital markets. Julianna Tatelbaum and Karen Tso asked Shell CEO Wael Sawan and LSEG CEO David Schwimmer to weigh in on the debate.

Breakdown
  • Major UK companies like AstraZeneca and Shell are reportedly considering US listings. 8s
  • Shell's CEO says the company has grown its US investor base without moving its listing. 48s
  • The London Stock Exchange Group CEO highlights regulatory improvements and international capital flows. 1m 16s
  • Some companies continue to pursue US listings, seeking access to more capital and higher valuations. 2m 27s
  • There is no clear evidence that moving to the US guarantees a valuation uplift for UK firms. 3m 35s
StockmarketEconomy